The rapid development of fluid biopsy is set to revolutionize the way doctors monitor and tackle the escalation of cancer and help in the early detection of the condition. The test, being sensitive enough to detect even a stray cancer cell, will see wide acceptance among patients who are at risk of developing cancer.
Global Fluid Biopsy Market-Market Dynamics
The global fluid biopsy market is driven by various factors like rising demand for non-invasive procedures, lower cost with greater accuracy to detect cancer cells and the increasing number of cancer cases being reported worldwide. The market is, however, restrained by various factors like the prevalence of alternative and better technologies like optical biopsies and needle biopsies, and the problems among healthcare physicians in the developing countries keen on using the traditional tissue-based biopsy techniques. The upcoming launch of multiple products (for fluid biopsy) and increasing government initiatives in many countries for pre-screening programs (for the detection of cancer) are some of the opportunities for the market players. However, they are also faced with challenges.
The global fluid biopsy market is segmented based on the type of cancer cells, the technology used and the indications. Based on the detection of different types of cancer cells, the market is further segmented into detection of circulating tumor cells, detection of circulating tumor DNA and detection of exosomes and microvesicles. The detection of circulating tumor cells is further segmented based on the different techniques involved in the cell search detection method, epic sciences detection method, Maintrac detection method and others. Based on technology, the market is segmented into digital PCR, NGS and others. Based on indications, the market is segmented into cancer, precancerous screening, and inflammatory conditions.
Based on geographical location, the fluid biopsy market can be divided into North America (USA, Canada and Mexico), Europe (France, UK, Germany, Spain, Portugal and Italy), Asia-Pacific (India, China, Japan, South Korea, Australia, and New Zealand), Middle East and Africa (GCC and South Africa) and Latin America (Brazil and Argentina).
Major Companies in the Sector Include:
Market analysis for the global fluid biopsy market, with region-specific assessments and competition analysis on the global and regional scale.
Market definition along with the identification of key drivers and restraints.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence this market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their market share.
Identification and analysis of the macro and micro factors that affect the global fluid biopsy market on both global and regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.
Insights on the major countries/regions in which this industry is blooming and identification of the regions that are still untapped.
1.1 Study Deliverables
1.2 Market Definition
1.3 Sizing Units
1.4 Base Currency
1.5 Review and Forecast Period Years
1.6 General Study Assumptions
2. Research Methodology
2.2 Analysis Methodology
2.3 Econometric Forecast Models
2.4 Research Assumptions
3. Executive Summary
4. Market Overview and Industry Trends
4.1 Porterâ€™s Five Force Analysis
4.1.1 Bargaining Power of Suppliers
4.1.2 Bargaining Power of Buyers
4.1.3 Degree of Competition
4.1.4 Threat of Substitution
4.1.5 Threat of New Entrants
5. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)
5.1 Market Drivers
5.1.1 Rising demand for non-invasive procedures
5.1.2 Lower cost with greater accuracy
5.1.3 Increase in the number of cancers being reported worldwide
5.2 Market Restraints
5.2.1 Alternative technologies like optical biopsies growing
5.2.2 Developing countries more keen in using traditional tissue based biopsy techniques
5.3 Market Opportunities
5.3.1 Many products in pipeline of development to be launched soon
5.3.2 Increasing pre-screening programs for detection of cancer
5.4 Key Challenges
6. Global Fluid Biopsy Market Segmentation
6.1 By Types
6.1.1 By Detection of Circulating Tumor Cells
188.8.131.52 Cell Search Detection method
184.108.40.206 Epic Sciences Detection Method
220.127.116.11 Maintrac Detection Method
18.104.22.168 Other Methods
6.1.2 By Detection of Circulating Tumor DNA
6.1.3 Exosomes and Micro Vesicles
6.2 By Technology
6.2.1 Digital PCR
6.3 By Indications
6.3.2 Pre-Cancerous Conditions
6.3.3 Inflammatory Conditions
7. Global Fluid Biopsy Market by Geography - Regional Shares and Forecast
7.1 North America
7.2.6 Rest of Europe
7.3.4 South Korea
7.3.5 Australia and New Zealand
7.3.6 Rest of Asia-Pacific
7.4 Middle East and Africa
7.4.2 South Africa
7.4.3 Rest of the Middle East and Africa
7.5 Latin America
7.5.3 Rest of Latin America
8. Competitive Landscape
8.1 Mergers & Acquisitions
8.2 New Product Launches
8.3 Agreements, Collaborations & Partnerships
9. Key Vendors
9.2 Bio-Rad Laboratories
9.5 Exosome Sciences
9.6 Guardant Health
9.7 Horizon Discovery
10. Analyst View